Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Original Article

The usefulness of contrast-enhanced ultrasonography in the early detection of hepatocellular carcinoma viability after transarterial chemoembolization: pilot study

Youn Zoo Cho, So Yeon Park, Eun Hee Choi, Soon Koo Baik, Sang Ok Kwon, Young Ju Kim, Seung Hwan Cha, Moon Young Kim

Clin Mol Hepatol. 2015;21(2):165-174. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.165

View: 8991 Download: 93 Web of Science: 17 Crossref: 16

Predictive factors of contrast-enhanced ultrasonography for the response to transarterial chemoembolization in hepatocellular carcinoma

Kil Hyo Park, Soon Ha Kwon, Yong Sub Lee, Soung Won Jeong, Jae Young Jang, Sae Hwan Lee, Sang Gyune Kim, Sang-Woo Cha, Young Seok Kim, Young Deok Cho, Hong Soo Kim, Boo Sung Kim, Yong Jae Kim

Clin Mol Hepatol. 2015;21(2):158-164. Published online June 26, 2015

DOI: https://doi.org/10.3350/cmh.2015.21.2.158

View: 7787 Download: 116 Web of Science: 8 Crossref: 6

Radiofrequency ablation of very-early-stage hepatocellular carcinoma inconspicuous on fusion imaging with B-mode US: value of fusion imaging with contrast-enhanced US

Ji Hye Min, Hyo Keun Lim, Sanghyeok Lim, Tae Wook Kang, Kyoung Doo Song, Seo-youn Choi, Hyunchul Rhim, Min Woo Lee

Clin Mol Hepatol. 2014;20(1):61-70. Published online March 26, 2014

DOI: https://doi.org/10.3350/cmh.2014.20.1.61

View: 8661 Download: 110 Web of Science: 49 Crossref: 47

1 |

Viewed By 5310	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5254	MAFLD: How is it different from NAFLD?
Viewed By 5155	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3870	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3806	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search